PD I Flashcards

1
Q

Voluntary movement originates in the ___ cortex and are mediated abd nodulated by the ______ and _____ systems

A

Motor (frontal) cortex; pyranidal and extrapyramidal systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The 2 tracts of the pyramidal system

A

Corticospinal tract

Corticobulbar tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Structures of the extrapyramidal system

A

Basal ganglia (Caudate, putamen, globus pallidus, substantia nigra, subthalamic nucleus)
Thalamus,
Cerebellum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Structures that make up the Basal ganglia

A

Caudate, putamen, globus pallidus,

substantia nigra, subthalamic nucleus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The _____ is a major target in the pharmacology of movement

disorders

A

basal ganglia–at the core if movement control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The activity of the motor cortex is increased by ________

A

excitatory (glutamatergic) thalamo-cortical connections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Excitatory motor control by _____ neurons is regulated by ______

A

excitatory (glutamatergic) thalamo-cortical connections;

GABAergic inhibitory neurons in the Gpi and SNr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BG Output neurons are…

A

GABAergic inhibitory neurons in the GPi and SNr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Role of ‘output neurons’

A

exert a tonic inhibitory effect on the thalamo-cortical neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The ‘output” neurons are regulated by

A

by the coordinated activity of neurons located in the basal ganglia, which form two major pathways (indirect and direct)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

2 pathways of BG

A

Indirect and direct; regulate ‘output’ neuron firing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Both the indirect and direct pathways originate with ____ neurons with ___ receptors

A

medium spiny GABAergic neuron; dopamine receptors (D1 or D2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dopamine receptors– __ receptors, __ types

A

5 receptors, in 2 types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

2 DA receptor types

A

D1-like

D2-like

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

D1-like receptors

A

D1 and D5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

D2-like receptors

A

D2, D3, D4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

D1R mechanism

A

activates adenylate cyclase and production of cAMP –> stimulatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

D2R mechanism

A

inhibits adenylate cyclase and decreases cAMP –> inhibitory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

D1Rs are _____ since they ___ neuronal excitability and D2Rs are ____ as they ____ neuronal exciatbility

A

D1Rs– Activating; Increase

D2Rs–inhibitory; decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Other contributions of D1 and D2Rs

A

D1R and D2R also modulate the activity of various ion channels resulting in opposite effects on neuronal excitability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Thalamocortical connects role

A

Stimulate motor activity (stim motor cortex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Striatal medium spiny GABAergic neurons: modulation/role

A

Role: integrate information from many sources
Receive excitatory synapses from cortical neurons, as well as stimulation from cholinergic striatal interneurons and dopaminergic modulation from the substantia nigra

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Activation of the ____ pathway
results in reduced activation of the
motor cortex. Overall ____ effect on movement

A

Activation of the INDIRECT pathway
results in reduced activation of the
motor cortex.
Overall INHIBITORY effect on movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Activation of indirect pathway

A

ACh –> excites GABA neurons –> inhibit GPe
1) –> less inhibition on GPi and SNr
2) –> inhibit STN –> less excitation of GPi and SNr
= can’t disinhibit movement (thalamus inhibited = no movement)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Output neurons w/ activation of indirect pathway

A

Over-excitation of output neurons –> can’t disinhibit thalamus = no movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Activation of Direct Pathway

A

Activate D1 receptor on GABA neurons–> inhibit GPi and SNr –> disinhibition of thalamus –> increase movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Output neurons w/ activation of direct pathway

A

Output neurons Inhibited –> thalamus disinhibited –> increased movement

28
Q

Net effect of activation of Direct pathway

A

results in increased excitation of the motor cortex (overall stimulatory effect on movement)

29
Q

Striatal neurons are densely innervated
by _____ afferent fibers from
the _____

A

Striatal neurons are densely innervated
by DOPAMINERGIC afferent fibers from
the SUBSTANTIA NIGRA PARS COMPACTA

30
Q

__ released in the striatum activates D1 and D2 receptors

A

Dopamine

31
Q

Binding to D1 receptors in the striatum ___ the ___ pathway

A

Binding to D1 receptors (activating receptors) activates the direct pathway

32
Q

Binding to D2 receptors in the striatum ___ the ___ pathway

A

Binding to D2 receptors (inhibitory receptors) inhibits the indirect pathway

33
Q

Overall effect of DA on movement

A

dopaminergic transmission in the
striatum overall facilitates movement
BY inhibiting indirect pathway and exciting direct pathway

34
Q

Damage to the BG causes

A

altered balance between direct and

indirect pathways leading to motor disorders

35
Q

2 types of movement disorders

A

1) hypokinetic

2) Hyperkinetic

36
Q

In Hypokinetic disorders, the ___ pathway dominates causing ___ output

A

Indirect pathway dominates causing increased inhibitory output
ex. PD

37
Q

In Hyperkinetic disorders, the ___ pathway dominates causing ___ output

A

Direct Pathway dominates causing decreased inhibitory output
ex. HD

38
Q

Most common neurodegenerative disorder after AD

A

PD

39
Q

__% of population over 65 is affected by PD and __% of cases are sporadic

A

1%; 95%

40
Q

Characteristic symptoms of PD

A
  • tremor
  • bradykinesia
  • rigidity
41
Q

T/F PD also has non-motor symptoms

A

TRUE
Non-motor features, including cognitive
impairment and psychiatric symptoms,
are also frequently present.

42
Q

The most affected neurons in PD are

A

DA neurons in the substantia nigra, which progressively die.
Up to 80% of DA neurons might be lost at the time of diagnosis

43
Q

Up to __% of DA neurons in the SNr may be lost at time of PD diagnosis

A

80%

44
Q

Loss of dopaminergic neurons in PD causes…

A

… a neurotransmitters imbalance in the striatum, over-activation of the indirect pathway, decreased stimulation of the direct pathway and reduced movement (bradykinesia)

45
Q

Control of D2 neurons (afferents)

A

The activity of D2 neurons in the striatum is regulated by the balanced activity of inhibitory dopaminergic and excitatory
cholinergic afferents

46
Q

T/F There is a cure for PD

A

There is no cure for PD, nor disease-modifying treatments.

The only approved drugs for PD treat symptoms, not the underlying pathogenic process

47
Q

Environmental factors affecting PD

A

Rotenone
Paraquat
MPTP/MPP+

48
Q

genetic actors affecting PD

A
Alpha-synuclein
Parkin PINK1
DJ1 LRRK2
VPS35 ATP13A2
GBA
49
Q

Neuronal dysfunction in PD

A

Neuronal dysfunction may start at synaptic terminal w/ neurons then atrophying
Only ~30% of DA neurons are lost but 50-60% of terminals are lost

50
Q

Sporadic PD is due to ___, but monogenic PD is also possible (but rarer)

A

Environmental factors such as Rotenone, Paraquat, MPTP/MPP+

51
Q

3 cases for PD etiology

A

Case 1 (complex): distinct genotype and environemental factors (onset ~65)
Case 2: one monogenic event (early onset ~35-40)
Case 3: Enviro event in young age (ex. exposure to toxins MPTP/injury)–onset before 30 yrs

52
Q

Most PD likely of ___ complex etiology

A

Complex

mix of genetics and enviro (~95% of cases)

53
Q

Genetics in PD

A

genetic risk factors are usually many polymorphisms in many genes –> predispose one to PD as they age

54
Q

Enviro factors in PD that increase risk

A
  • concussion (head injury)
  • pesticides
    BUT coffee and tobacco DECREASE risk
55
Q

MPTP/MPP+

A

MPTP converted to MPP+ which is a cation that enters Da neurons –> inhibits mitochondrial respiratory complex I

56
Q

Rotenone, paraquat

A

Rotenone (pesticide), paraquat (herbicide)

both inhibitors of mitochondrial respiratory complec I

57
Q

Heavy metals

A

Probable risk
Mn, Fe
Cause mitochondrial dysfunction, oxidative stress, impaired protein degradation

58
Q

Commonalities b/t environmental toxin

A

All toxins affect the mitochondria–may tell ys that it function may play an important role in PD pathogenesis

59
Q

Drug-induced Parkinson–which drugs

A

Typical antipsychotic drugs (chlorpromazine etc.) and neuroleptic agents may induce parkinsonism

60
Q

T/F Drug-induced PD is reversible

A

TRUE

61
Q

Cause of drug-induced PD

A

Caused by D2 receptor antagonism

62
Q

Those more likely to develop drug-induced PD

A

Most common among elderly patients, probably due to smaller reserve of dopaminergic neurons
A genetic component predisposes to drug-induced parkinsonism

63
Q

Drug-induced PD timeline

A

Symptoms usually appear within days to months after drug use and disappear over weeks or months after cessation of the drug.

64
Q

Goal in treating PD

A

to decrease the activity of the indirect
pathway, by increasing dopaminergic
transmission or inhibiting cholinergic activity in the basal ganglia

65
Q

Strategies in treated PD (pharmacologically)

A
  • Supplementation with L-DOPA (DA does not cross the BBB)
  • Inhibition of dopamine catabolism (decreased DA breakdown)
  • Use of dopamine receptor (D2R) agonists (inhibit indirect pathway)
  • Muscarinic antagonists (balance Ach and DA activity to modulate indirect pathway)